{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:02:24Z","timestamp":1761930144516},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>The incidence of pregnancy-associated breast cancer (PABC) is increasing nowadays, and its diagnosis and treatment remain complicated due to the consideration of the fetus. The available data on PABC are primarily derived from case reports since there are ethical restrictions on conducting randomized clinical trials. In the present work, we reported a case of the human epidermal growth factor receptor 2 (HER2)-positive PABC and described the diagnosis and treatment for such type of breast cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 27-year-old patient was admitted to our hospital with the complaints of right breast mass for 3 days, and she was a first-time pregnant woman with a single live intrauterine fetus at 26 + 3 weeks of gestation. Physical examination of the right breast revealed a palpable and hard mass with obscure boundaries (5.0\u200acm\u200a\u00d7\u200a4.0\u200acm) in the upper outer quadrant. Significant axillary lymph nodes (2.0\u200acm) were also present.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>PABC.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>To protect the fetus, breast ultrasonography was used to test her breast mass, a core needle biopsy was adopted to confirm the diagnosis, and abdominal ultrasound and chest X-ray were used to evaluate the metastasis. The patient was scheduled for neoadjuvant therapy using bi-weekly pirarubicin in combination with cyclophosphamide (AC) without anti-HER2 therapy for consideration of the fetus's safety. After 4 cycles of AC, the patient delivered a healthy male infant. After the delivery, all the treatments were carried out according to the standard recommendation for HER2\u200a+\u200abreast cancer as non-pregnant patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After the surgery, the disease-free survival for the patient was 12 months until brain metastasis was diagnosed. She was still undergoing second-line anti-HER2 therapy and currently in a stable situation. Besides, the child was also healthy so far.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>The methods for the diagnosis and treatment of PABC that result in teratogenesis should be avoided to protect the fetus. Mammogram and chest X-ray were safe approaches for the fetus. Moreover, chemotherapy-based on pirarubicin in combination with cyclophosphamide had no risk to the fetus.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000022929","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T19:04:22Z","timestamp":1603911862000},"page":"e22929","source":"Crossref","is-referenced-by-count":3,"title":["Diagnosis and treatment of advanced HER2-positive breast cancer in young pregnant female"],"prefix":"10.1097","volume":"99","author":[{"given":"Tiantian","family":"Tang","sequence":"first","affiliation":[{"name":"Breast Center, the Fourth Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueping","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, the Fourth Hospital of Hebei Medical University, Shijiazhuang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Yang","sequence":"additional","affiliation":[{"name":"Breast Center, the Fourth Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[{"name":"Breast Center, the Fourth Hospital of Hebei Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jogoh.2018.03.003","article-title":"What about sentinel lymph node biopsy for early breast cancer during pregnancy?","volume":"5","author":"Balaya","year":"2018","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0037-1599133","article-title":"Management of breast cancer during pregnancy: are we compliant with current guidelines?","volume":"7","author":"Shlensky","year":"2017","journal-title":"AJP Rep"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jamaoncol.2015.2112","article-title":"Breast cancer in young women: rare disease or public health problem?","volume":"1","author":"Rosenberg","year":"2015","journal-title":"JAMA Oncol"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ctrv.2008.01.002","article-title":"Cancer in pregnancy: gaps, challanges and solutions","volume":"34","author":"Pereg","year":"2008","journal-title":"Cancer Treat Rev"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s13224-019-01249-9","article-title":"Pregnancy-associated breast cancer: a realistic approach","volume":"69","author":"Ramesh","year":"2019","journal-title":"J Obstet Gynaecol India"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12885-020-06724-5","article-title":"Clinical features and survival of pregnancy-associated breast cancer: a retrospective study of 203 cases in China","volume":"20","author":"Han","year":"2020","journal-title":"BMC Cancer"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10549-020-05585-7","article-title":"Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period","volume":"180","author":"O'Sullivan","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"R8-20230916","first-page":"e5240","article-title":"Diagnosis and management of metastatic breast cancer in a 33-year-old pregnant female: a case report","volume":"11","author":"Albach","year":"2019","journal-title":"Cureus"},{"key":"R9-20230916","first-page":"134","article-title":"Imaging in pregnancy-associated breast cancer: a case report","volume":"26","author":"Untanas","year":"2019","journal-title":"Acta Med Litu"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/tbj.13714","article-title":"Pregnancy associated breast cancer","volume":"26","author":"Macdonald","year":"2020","journal-title":"Breast J"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3390\/cancers11111669","article-title":"Breast cancer during pregnancy-current paradigms","volume":"11","author":"Alfasi","year":"2019","journal-title":"Paths to Explore Cancers (Basel)"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1634\/theoncologist.2010-0262","article-title":"Breast cancer and pregnancy: current concepts in diagnosis and treatment","volume":"15","author":"Litton","year":"2010","journal-title":"Oncologist"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3332\/ecancer.2019.930","article-title":"Chemotherapy and anti-HER2 therapy in metastatic breast cancer in pregnancy followed by surgical treatment","volume":"13","author":"Berwart","year":"2019","journal-title":"Ecancermedicalscience"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.breast.2017.07.014","article-title":"Whole body MRI for systemic staging of breast cancer in pregnant women","volume":"35","author":"Peccatori","year":"2017","journal-title":"Breast"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-008-0159-2","article-title":"Weekly epirubicin in the treatment of gestational breast cancer (GBC)","volume":"115","author":"Peccatori","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/COC.0b013e3181a44ca9","article-title":"Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry","volume":"33","author":"Cardonick","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bpobgyn.2015.10.007","article-title":"Chemotherapy in pregnancy","volume":"33","author":"Ngu","year":"2016","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/tbj.13156","article-title":"Neonatal outcomes of pregnancy-associated breast cancer: population-based study on 11 million births","volume":"25","author":"Shechter Maor","year":"2018","journal-title":"Breast J"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-012-2368-y","article-title":"Trastuzumab administration during pregnancy: a systematic review and metaanalysis","volume":"137","author":"Zagouri","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"R20-20230916","first-page":"6","article-title":"Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences","volume":"1","author":"Peccatori","year":"2018","journal-title":"Cancer Biol Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022929","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:58:54Z","timestamp":1694829534000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022929"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":20,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022929","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,30]]}}}